Dr. Raskin is a psychiatrist and academic with 20 years of international pharmaceutical experience in neuroscience drug development, lifecycle preparation, launch, and commercialization VANCOUVER, BC, May 20, 2021 /CNW/ – Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) (FRA: 6MH) ( “MINDCURE” or the “Company”), a leader in advanced proprietary technology for psychedelic therapy…


Previous articleWebinar with Tim Cools of Psychedelic Experience
Next articleFormer Senate Majority Leader Tom Daschle Appointed Special Adviser to Field Trip Health Ltd.